骨肉瘤
佐剂
医学
干扰素
癌症研究
肿瘤科
免疫学
作者
Hans Strander,Henric C. F. Bauer,Otte Brosjö,Andris Kreicbergs,Johan Lindholm,Ulf Nilsonne,Claes Silfverswärd,Alfred Szamosi
出处
期刊:Cancer treatment and research
日期:1993-01-01
卷期号:: 29-32
被引量:13
标识
DOI:10.1007/978-1-4615-3518-8_5
摘要
The protocols of Rosen and collaborators have been used for several years in Scandinavia [1], with the exception of our institution, where adjuvant IFN has been utilized for 20 years [2]. The present report is an update of our IFN-treated osteosarcoma series conducted over the period 1971–1984; control patients representing a high-dose chemotherapy group and a nonadjuvant group are also presented.
科研通智能强力驱动
Strongly Powered by AbleSci AI